SDC DSR Capsules combine Rabeprazole Sodium, a proton pump inhibitor, with Domperidone, a prokinetic agent, to deliver comprehensive management of acid-related gastrointestinal conditions. Rabeprazole suppresses excess gastric acid secretion, while Domperidone enhances gastric emptying and helps relieve nausea and reflux symptoms.

This advanced formulation is widely prescribed in the treatment of gastroesophageal reflux disease (GERD), acid dyspepsia, peptic ulcer disease, and conditions associated with delayed gastric motility. The enteric-coated (EC) and sustained-release (SR) design ensures targeted action, prolonged relief, and improved patient compliance.

Manufactured under strict quality standards, SDC DSR Capsules offer consistent efficacy and safety when used as directed by healthcare professionals.